Research Topics
| Adam J WolfbergSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Association of rheumatologic disease with preeclampsiaAdam J Wolfberg
Department of Obstetrics and Gynecology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
Obstet Gynecol 103:1190-3. 2004..To determine whether maternal rheumatologic disease is associated with an increased risk of adverse obstetric or neonatal outcomes...
Role of obesity in the surgical management of advanced-stage ovarian cancerAdam J Wolfberg
Department of Obstetrics and Gynecology, Brigham and Women s Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
J Reprod Med 49:473-6. 2004....
Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancyAdam J Wolfberg
Division of Gynecologic Oncology, New England Trophoblastic Disease Center, Donald P Goldstein M D Trophoblastic Tumor Registry, Harvard Medical School, Boston, Massachusetts, USA
Obstet Gynecol 104:551-4. 2004..Our objective was to determine the risk of disease recurrence after hCG spontaneously declines to undetectable levels...
Dads as breastfeeding advocates: results from a randomized controlled trial of an educational interventionAdam J Wolfberg
Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
Am J Obstet Gynecol 191:708-12. 2004....
Obstetric and neonatal outcomes associated with maternal hypothyroid diseaseAdam J Wolfberg
Department of Obstetrics and Gynecology, Brigham and Women s Hospital, Boston, MA 02115, USA
J Matern Fetal Neonatal Med 17:35-8. 2005..We sought to determine whether women with treated hypothyroid disease were more likely than women without thyroid disease to suffer adverse obstetric or neonatal outcomes or to deliver a child with a congenital anomaly...
Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancyAdam J Wolfberg
Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women s Hospital, Boston, MA 02115, USA
Obstet Gynecol 106:548-52. 2005..Our objective was to develop human chorionic gonadotropin (hCG) criteria that establish a patient's risk of developing persistent GTN or achieving remission from their baseline risk within a few weeks of molar evacuation...
Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapyWhitfield B Growdon
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, USA
J Reprod Med 55:279-84. 2010..To determine whether any clinical parameters predict the need for multiagent chemotherapy for treatment of low-risk gestational trophoblastic neoplasia (GTN) after the development of methotrexate (MTX) resistance...
Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnanciesWhitfield B Growdon
Donald P. Goldstein, M.D, Trophoblastic Tumor Registry, New England Trophoblastic Disease Center, USA
J Reprod Med 51:871-4. 2006..CONCLUSION: Women with partial mole who have elevated hCG levels within the first few weeks after molar evacuation are at increased risk for developing GTN...
Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancyColleen M Feltmate
Donald P Goldstein, M D, Trophoblastic Tumor Registry, New England Trophoblastic Disease Center, USA
J Reprod Med 51:902-6. 2006..To identify clinical characteristics associated with developing persistent gestational trophoblastic neoplasia (GTN) after partial hydatidiform molar pregnancy (PHM)...
Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasiaWhitfield B Growdon
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Massachusetts General Hospital, Boston, USA
Gynecol Oncol 112:353-7. 2009..To identify clinical factors associated with requiring more than a single course of Methotrexate (MTX) to achieve remission among women with low-risk postmolar gestational trophoblastic neoplasia (GTN)...
Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancyAdam J Wolfberg
Department of Obstetrics, Gynecology, and Reproductive Biology, Division of Gynecologic Oncology, Brigham and Women s Hospital, Boston, Massachusetts, USA
Obstet Gynecol 108:393-6. 2006..We evaluated the risk of gestational trophoblastic neoplasia (GTN) for women with partial molar pregnancy whose human chorionic gonadotropin (hCG) levels fall spontaneously to undetectable levels using a sensitive hCG assay...
Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancyAdam J Wolfberg
Obstet Gynecol 107:743. 2006
